1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Analysis of the Western European Immunochemistry Market : Integrated Systems with Ultrasensitive Immunoassay Platform Drive Growth

Methodology

For Market Engineering research, Frost & Sullivan uses tried and tested marketing techniques to provide structure to the research and an easy format to compare results across different countries and markets over time. This project was carried out using primary (telephone or face-to-face interviews) and secondary (published and online material) research as the principle methods of data gathering. The focus of the interviews for this project was primarily the respondent types outlined below.
•Industry participants
•End users
•Key regulatory bodies
•Frost & Sullivan published research services
•Decision support databases
•Country-specific industry forecasts
•Proprietary databases

Key Findings

•The Western European immunochemistry market will continue to grow from $ x million in 2014 to $ x million in 2021 at a compound annual growth rate (CAGR) of x % from 2014 to 2021.
•Several strategic partnerships and merger and acquisition activities are being witnessed in the immunochemistry market. Examples include Johnson & Johnson’s Ortho Clinical Diagnostics division that has been divested to the Carlyle Group. Roche has renewed partnership with Hitachi to develop, manufacture, and strengthen its immunochemistry product portfolio.
•Multiplexed immunoassay platforms are considered the next growth area. Immunoassays such as ChemiLuminescent ImmunoAssay (CLIA), though expensive, are on demand as the preferred choice.
•However, as laboratories are moving towards high throughput and highly sensitive assays, the market is expected to witness a shift from traditional enzyme-linked immunosorbant assay (ELISA) towards advanced technologies.
•On the technology front, immunochromatographic assays, magnetorestrictive methods, field-effect transistor methods based on nanotubes, nanowires, and nanoribbons are the next generation technologies that are being worked on to enhance immunoassay diagnostic tests.

Scope and Segmentation

•This study provides a segment overview, market engineering measurements, revenue forecasts, and key trends for immunoassay, clinical chemistry, and integrated analysers.
•This study covers the following Western European countries:
oThe United Kingdom, Germany, France, Italy, and Spain
oBenelux: Belgium, the Netherlands, and Luxembourg
oScandinavia: Denmark, Norway, Sweden, and Finland

Key Questions This Study Will Answer

What are the key factors driving the market and the barriers that need to be resolved?
What is the current market scenario? How much growth is expected?
Which are the major market segments and what are the important trends?
Which are the key market participants involved, and where do they stand?
What are the key application areas that will expand the horizon, and how will they impact the market in the future?
What is the future of the market in Western Europe, and what should participants do to succeed?

Table Of Contents

Analysis of the Western European Immunochemistry Market : Integrated Systems with Ultrasensitive Immunoassay Platform Drive Growth
Methodology 9
Executive Summary 10
• Key Findings 11
• Scope and Segmentation 12
• Key Questions This Study Will Answer 13
• Market Engineering Measurements 14
• CEO's Perspective 15
• Key Companies to Watch 16
• Recent Market Developments 17
• 3 Big Predictions 18
Market Overview 19
• Market Segmentation 20
• Immunochemistry Market—Common Tests 22
• Defining Healthcare Trends in the Future 24
Competitive Playbook 25
• New Market Opportunities 26
• Merger, Acquisition, and Partnership Assessment 29
Drivers, Restraints, and Trends—Total Immunochemistry Market 36
• Market Drivers 37
• Market Restraints 38
• Impact Mapping of Drivers and Restraints 39
• Market Growth Opportunity Analysis 40
Forecast and Trends—Total Immunochemistry Market 41
• Market Engineering Measurements 42
• Forecast Assumptions and Definitions 43
• Revenue Forecast 44
• Instruments vs. Reagents Revenue Forecast 45
• Revenue Forecast Discussion 46
• Percent Revenue Forecast by Region 47
• Revenue Forecast by Region 48
• Key Market Trends 49
• Pricing Analysis 50
• Segment Lifecycle Analysis 51
Competitive Environment 52
• Market Share 53
• Market Share Analysis 54
Immunoassay Segment Analysis 55
• Market Engineering Measurements 56
• Revenue Forecast 57
• Revenue Forecast Discussion 58
• Metrics Analysis 59
• Market Share 60
• Market Share Analysis 61
• Competitive Structure 62
Clinical Chemistry Segment Analysis 63
• Market Engineering Measurements 64
• Revenue Forecast 65
• Revenue Forecast Discussion 66
• Metrics Analysis 67
• Market Share 68
• Market Share Analysis 69
• Competitive Structure 70
Integrated Analysers Segment Analysis 71
• Market Engineering Measurements 72
• Revenue Forecast 73
• Revenue Forecast Discussion 74
• Metrics Analysis 75
• Market Share 76
• Market Share Analysis 77
• Competitive Structure 78
The United Kingdom Analysis 79
• Revenue Forecast 80
• Revenue Forecast Discussion 81
Germany Analysis 82
• Revenue Forecast 83
• Revenue Forecast Discussion 84
France Analysis 85
• Revenue Forecast 86
• Revenue Forecast Discussion 87
Italy Analysis 88
• Revenue Forecast 89
• Revenue Forecast Discussion 90
Spain Analysis 91
• Revenue Forecast 92
• Revenue Forecast Discussion 93
Benelux Analysis 94
• Revenue Forecast 95
• Revenue Forecast Discussion 96
Scandinavia Analysis 97
• Revenue Forecast 98
• Revenue Forecast Discussion 99
Key Company Profiles 100
• Roche Diagnostics 101
• Siemens Healthcare Diagnostics 103
• Abbott Diagnostics 106
• Ortho Clinical Diagnostics 108
• Thermo Fisher Scientific 110
• Beckman Coulter (Danaher Group) 112
The Last Word 114
• The Last Word—3 Big Predictions 115
• The Last Word—Discussion 116
• Legal Disclaimer 119
Appendix 120
• Drivers Explained 121
• Restraints Explained 123
• Total Healthcare Expenditure 127
• Public Healthcare Expenditure 129
• Private Healthcare Expenditure 131
• Number of Hospital Beds 133
• Number of Hospitals 135
Additional Sources of Information on Diabetes 137
• List of Companies in “Others” 138
• Market Engineering Methodology 139
• List of Exhibits 143

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.